Table 2.
Laboratory data.
| Total | Cluster 1 | Cluster 2 | Cluster 3 | P value | |
|---|---|---|---|---|---|
| Standard risk | High TE- and MB- risk | High M- and HF- risk | |||
| (n = 573) | (n = 429) | (n = 24) | (n = 120) | ||
| Systolic blood pressure, mmHg | 0.156 | ||||
| ≥150 | 81 (14.1) | 53 (12.4) | 6 (25.0) | 22 (18.3) | |
| 100–149 | 471 (82.2) | 358 (83.4) | 17 (70.8) | 96 (80.0) | |
| <100 | 21 (3.7) | 18 (4.2) | 1 (4.2) | 2 (1.7) | |
| Body mass index, kg/m2 | 0.071 | ||||
| ≥25 | 135 (23.6) | 97 (22.6) | 6 (25.0) | 32 (26.7) | |
| 18.0–24.9 | 397 (69.3) | 305 (71.1) | 13 (54.2) | 79 (65.8) | |
| <18.0 | 41 (7.2) | 27 (6.3) | 5 (20.8) | 9 (7.5) | |
| Albumin, g/dL | <0.001 | ||||
| ≥4.5 | 45 (7.9) | 45 (10.5) | 0 (0.0) | 0 (0.0) | |
| 3.5–4.4 | 464 (81.0) | 362 (84.4) | 15 (62.5) | 87 (72.5) | |
| <3.5 | 64 (11.2) | 22 (5.1) | 9 (37.5) | 33 (27.5) | |
| Hemoglobin, g/dL | <0.001 | ||||
| ≥13.0 | 246 (42.9) | 203 (47.3) | 8 (33.3) | 35 (29.2) | |
| 11.0–12.9 | 249 (43.5) | 194 (45.2) | 9 (37.5) | 46 (38.3) | |
| <11.0 | 78 (13.6) | 32 (7.5) | 7 (29.2) | 39 (32.5) | |
| Estimated glomerular filtration rate, mL/min/1.73 m2 | <0.001 | ||||
| ≥60 | 208 (36.3) | 159 (37.1) | 15 (62.5) | 34 (28.3) | |
| 30–59 | 232 (40.5) | 192 (44.8) | 5 (20.8) | 35 (29.2) | |
| <30 | 133 (23.2) | 78 (18.2) | 4 (16.7) | 51 (42.5) | |
| Estimated creatinine clearance, mL/min | <0.001 | ||||
| ≥50 | 247 (43.1) | 205 (47.8) | 18 (75.0) | 24 (20.0) | |
| 30–49 | 270 (47.1) | 194 (45.2) | 4 (16.7) | 72 (60.0) | |
| <30 | 56 (9.8) | 30 (7.0) | 2 (8.3) | 24 (20.0) |
TE- and MB-, thromboembolism and major bleeding; M- and HF-, mortality and heart failure.